The antiviral potential of 4′-fluorouridine as an oral treatment against RSV...
New research reports 4’-Fluorouridine (4′-FlU) as an oral antiviral against RSV and SARS-CoV-2.
View ArticleVaccines and monoclonal antibodies being developed for respiratory syncytial...
A new study reviews recent advancements made in the development of RSV immunoprophylactic measures.
View ArticleThe maternal RSV vaccine from Pfizer protects newborns against severe illness
Pfizer announced its maternal vaccine against RSV to be almost 82% effective in protecting infants for the first 90 days of life against severe illness.
View ArticleRSV and kids: What you need to know
An overview on the prevalence, symptoms, and management of RSV in children.
View ArticleSurge in RSV cases – how worried should you be?
RSV hospitalizations are reaching similarly high levels much earlier than normal this year.
View ArticleResearchers identify a novel RSV variant associated with prolonged infection
Researchers examine pathogen or host genetic risk factors for RSV infection, as well as whether certain viral variants are associated with prolonged infection.
View ArticlePreparing for epidemics now and in the future
The World Health Organization (WHO) recently conducted a virtual press conference on global health emergencies on November 16, 2022. Margaret Harris hosted the conference at WHO Headquarters in Geneva....
View ArticleAre nasal-spray vaccines the solution to respiratory infectious diseases?
A recent study published in the journal Trends in Molecular Medicine reviewed the current efforts in developing nasal vaccines, delivery systems, and clinical applications for preventing respiratory...
View ArticleRSV causes 160,000 hospitalizations every year in the EU, according to new study
Researchers estimate hospitalizations associated with respiratory syncytial virus infection in the European Union.
View ArticleThe economic burden of RSV infections in low and middle-income countries
Researchers discuss the cost-of-illness associated with RSV infections among children in low and middle-income countries.
View Article